Community

Phil Vanek, Ph.D.

Chief Technical Officer, Gamma Biosciences

Phil Vanek is General Manager, Cell & Gene Therapy Strategy and Business Development at GE Healthcare Life Sciences. An entrepreneurial and strategic international business leader, Phil Vanek has led marketing, business development, innovation and general management positions in start-up and established biotechnology companies. Phil received his Ph.D. in Biochemistry and Molecular Biology at Georgetown University Medical Center.

Contributions

Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?

Community

Phil Vanek, Ph.D.

Chief Technical Officer, Gamma Biosciences

Contributions

Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?

Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?

Q: What technology do you foresee leading the industry over the coming decade, both in terms of real approvals and general impact?